Dickerson, J. C., Caswell-Jin, J. L., Riaz, F., Goldhaber-Fiebert, J. D., Alarid-Escudero, F. (2025). Reply to: Comment on Human Epidermal Growth Factor Receptor 2–Low Metastatic Breast Cancer Treatment Costs and Cost-Effectiveness. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01879